Moffitt Cancer Center Hosts Ft. Lauderdale Awareness Luncheon to Benefit Cancer Research

January 29, 2015

WHO: Moffitt Cancer Center, the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, will host a cancer awareness luncheon.

WHAT: A cure for cancer will one day be discovered in a research laboratory, so funding new advancements is critical to help put an end to the disease. Moffitt’s Center Director, Thomas Sellers, Ph.D., MPH, will moderate an awareness luncheon to explain how research funds help advance the mission of preventing and curing cancer.

Additionally, Scott Antonia, MD, Ph.D., will discuss how the body’s own immune system can be used to fight lung cancer and new immunotherapy treatment options for patients. John Cleveland, Ph.D., will discuss the role of genetics in cancer, as well biological factors that could lead to developments in treatment and care. Anna Giuliano, Ph.D. will address cancer prevention efforts and describe the role of Moffitt’s Center for Infection Research in Cancer plays in identifying infection cancer-causing agents, such as HPV.

WHEN: Wednesday, Feb. 11, 11:30 a.m.

WHERE: Huizenga Pavilion at the Broward Center for the Performing Arts, 201 Southwest 5th Avenue Ft. Lauderdale, Fla. 33312

CONTACT: For more information visit or call 813-745-3192.

About Moffitt Cancer Center
Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the top-ranked cancer hospital in the Southeast and has been listed in U.S. News & World Report as one of the “Best Hospitals” for cancer care since 1999. With more than 4,500 employees, Moffitt has an economic impact in Florida of nearly $1.6 billion. For more information, visit, and follow the Moffitt momentum on FacebookTwitter and YouTube.